Publications by authors named "Alexa B Kimball"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

9,771

Total Likes

303

Extended Reach

305,343

Social Features

37
A
A single-blinded, randomized, controlled clinical trial evaluating the effect of face washing on acne vulgaris.
Joanna Mimi Choi, Vincent K Lew, Alexa B Kimball

Pediatr Dermatol· January 2007

Videos about Article: user user user 1

4 30 8

View All Article and Social Media Activity
D
Double-blinded, placebo-controlled trial of green tea extracts in the clinical and histologic appearance of photoaging skin.
Annie E Chiu, Joanna L Chan, Dale G Kern, Sabine Kohler, Wingfield E Rehmus, Alexa B Kimball

July 2005

Videos about Article: user user

2 1 3 11

View All Article and Social Media Activity
D
Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis.
April W Armstrong, Richard B Warren, Howard Sofen, Lynda Spelman, Misti Linaberry, Alexa B Kimball

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient-reported outcomes for hidradenitis suppurativa.
John R Ingram, Magdalena B Wozniak, Anna Passera, Lorenz Uhlmann, Angela Llobet Martinez, Alexa B Kimball

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension.
Christopher J Sayed, Brian Kirby, Amit Garg, Haley B Naik, Alexa B Kimball

J Am Acad Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a morphological hidradenitis suppurativa phenotype algorithm (HS-KAPPA).
Martina L Porter, Anusha M Kumar, Sophio Kirimlishvili, Corey L Snyder, Ruby S Gibson, Alexa B Kimball

Br J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled phase 2 study of eltrekibart, a novel septa-specific monoclonal antibody to CXCR1/2 ligands, in adults with hidradenitis suppurativa.
Seth Forman, Dipak R Patel, Alexa B Kimball, Tarannum Jaleel, Vivian Laquer

J Am Acad Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with academic promotion among US academic dermatologists.
G Ege Eskibozkurt, Emma Beagles, Li-Chi Chen, Alexa B Kimball, Allen F Shih

J Am Acad Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The P2X7-NLRP3 inflammasome inhibitor AZD9056 has no significant effect on hidradenitis suppurativa clinical disease activity but restores cytokine production in peripheral blood mononuclear cells: Results of a phase 2 trial.
James M Kilgour, Hal Landy, Alexa B Kimball, Barry I Resnik, Milan J Anadkat

J Am Acad Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative life course impairment: Evidence for hidradenitis suppurativa.
Maneli Doroudian Tehrani, Ruby S Gibson, Corey L Snyder, Martina L Porter, Alexa B Kimball

J Eur Acad Dermatol Venereol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab in the Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Pooled Pharmacokinetics and Safety Results From the SUNSHINE and SUNRISE Phase 3 Studies.
Afsaneh Alavi, Ziad Reguiai, Gregor B E Jemec, Alice B Gottlieb, Magdalena B Wozniak, Alexa B Kimball

Int J Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2, Randomized, Placebo-Controlled Study of Bermekimab in Moderate-to-Severe Hidradenitis Suppurativa.
Seth Forman, Lea Kephart, Takayuki Ota, Jeff Pawlikowski, Jingzhi Jiang, Alexa B Kimball

J Invest Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study.
Amit Garg, Yvonne Geissbühler, Emma Houchen, Nilesh Choudhary, Disha Arora, Alexa B Kimball

Am J Clin Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Long-Term Pain Reduction with Secukinumab in Moderate to Severe Hidradenitis Suppurativa: A Post Hoc Analysis of the SUNSHINE and SUNRISE Phase 3 Trials.
John R Ingram, Jacek C Szepietowski, Lukasz Matusiak, Georgios Kokolakis, Magdalena B Wozniak, Alexa B Kimball

Dermatol Ther (Heidelb)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo-controlled study.
Lindsay S Ackerman, Bethanee J Schlosser, Tianyu Zhan, Vimal H Prajapati, Scott Fretzin, Alexa B Kimball

J Am Acad Dermatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Satisfaction in Patients with Hidradenitis Suppurativa: A Real-World Survey from the EU5 and USA.
John R Ingram, Vincenzo Bettoli, Jasmine I Espy, Georgios Kokolakis, Antonio Martorell, Alexa B Kimball

Dermatology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations.
Raed Alhusayen, Serena Dienes, Megan Lam, Afsaneh Alavi, Ali Alikhan, Alexa B Kimball

J Am Acad Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hidradenitis Suppurativa Epidemiology.
Sydney L Look-Why, Sophio Kirimlishvili, Martina L Porter, Alexa B Kimball

Dermatol Clin· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial.
Alexa B Kimball, Falk G Bechara, Aysha Badat, Evangelos J Giamarellos-Bourboulis, Alice B Gottlieb

Br J Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-Reactive Protein and Response to Adalimumab in Patients With Hidradenitis Suppurativa: A Post Hoc Analysis of 2 Randomized Clinical Trials.
Simon J Gunter, Martina L Porter, Alexa B Kimball

JAMA Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prednisone and amoxicillin/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study.
Ruby S Gibson, Corey L Snyder, Martina L Porter, Alexa B Kimball

Int J Womens Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing Reports.
Uma Mahadevan, Gweneth Levy, Lianne Gensler, Mira Ali, Ana P Lacerda, Alexa B Kimball

Drug Saf· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo responders with moderate-to-severe hidradenitis suppurativa experience declines in inflammation as measured by C-reactive protein: a post hoc analysis of two double-blinded, randomized-controlled trials.
Simon J Gunter, Martina L Porter, Alexa B Kimball

Int J Womens Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hidradenitis Suppurativa: New Targets and Emerging Treatments.
Julia L Gao, Tracey S Otto, Martina L Porter, Alexa B Kimball

Am J Clin Dermatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender Equity and Academic Dermatology: Are we giving the right advice?
Alexa B Kimball

J Eur Acad Dermatol Venereol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
Alexa B Kimball, Gregor B E Jemec, Christopher J Sayed, Joslyn S Kirby, Errol Prens

Lancet· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review.
Corey L Snyder, Ruby S Gibson, Stella X Chen, Martina L Porter, Alexa B Kimball

Int J Womens Dermatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis